Search - tctmd.com

Presenter: Lisbeth Antonsen, Lisette Okkels Jensen, Michael Maeng, Per Thayssen, Evald H?j Christiansen, Knud N?rregaard Hansen, Anne Kaltoft, Henrik Steen Hansen, Leif Thuesen, Jens Flensted Lassen

January 31, 2013

News Daily News

BMS vs. MIDCAB at 10 Years: Results Similar for LAD Disease, TVR Higher with PCI

Jason Kahn

January 24, 2013

News Daily News

Novel Anti-inflammatory May Reduce Restenosis After BMS in High-Risk Patients

L.A. McKeown

January 13, 2013

News Daily News

La CABG es Más Rentable a Largo Plazo en Pacientes Diabéticos con Enfermedad Multivaso

Yael L. Maxwell

January 09, 2013

News Daily News

CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term

Yael L. Maxwell

January 09, 2013

Advertisement

Drug-Eluting Balloons Lower TLR in Diabetics with Critical Limb Ischemia

SES Show Advantage Over ZES, PES for Diabetic Patients

Los SLS Sacan Ventaja a los SLZ y SLP en Pacientes Diabéticos

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Paclitaxel Delivery Key to PAD Intervention

Meta-analysis: DES Beneficial But May Not Save Limbs, Improve Survival in PAD Patients

Meta análisis: Los SLF son Beneficiosos pero podrían No salvar las Extremidades ni Mejorar la Supervivencia en Pacientes con EAP

ESSENCE-DIABETES II Trial

Mortality Varies by Revascularization Method in Dialysis Patients

La Colchicina Reduce la Reestenosis de los SMD en Pacientes Diabéticos

Colchicine Reduces BMS Restenosis in Diabetic Patients

Colchicine Treatment for Prevention of In-BMS Restenosis in Diabetics

Study Looks at Adding Corticosteroid Treatment to Bare-Metal Stenting

Estudio investiga la adición del tratamiento con corticosteroides a la colocación del stent de metal desnudo (SMD)

ISAR-DESIRE 3 Published: Paclitaxel-Eluting Balloons Match PES for DES Restenosis

Intimal Hyperplasia and Vascular Remodeling after Everolimus-eluting and Sirolimus-eluting Stent Implantation in Diabetic Patients. The Randomized Diabetes and Drug-Eluting Sten...

BMS vs. MIDCAB at 10 Years: Results Similar for LAD Disease, TVR Higher with PCI

Novel Anti-inflammatory May Reduce Restenosis After BMS in High-Risk Patients

La CABG es Más Rentable a Largo Plazo en Pacientes Diabéticos con Enfermedad Multivaso

CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content